The Structure of OMCI, a Novel Lipocalin Inhibitor of the Complement System

Journal of Molecular Biology

Volumn 369, Issue 3, 2007, Pages 784-793

  Roversi, Pietro ^a   Lissina, Olga ^b   Johnson, Steven ^a   Ahmat, Nurfilza ^a,b   Paesen, Guido C ^b   Ploss, Kerstin ^c   Boland, Wilhelm ^c   Nunn, Miles A ^b   Lea, Susan M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^c MAX PLANCK INSTITUTE FOR CHEMICAL ECOLOGY   (Germany)

Author keywords

complement C5; complement inhibitor; lipocalin; OmCI; tick

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A; FATTY ACID DERIVATIVE; LIPOCALIN; PROTEIN; PROTEIN INHIBITOR; PROTEIN OMCI; RICINOLEIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; COMPLEMENT ACTIVATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MASS SPECTROMETRY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; TICK BITE;

ARGASIDAE; IXODIDA; ORNITHODOROS MOUBATA;

EID: 34248165965     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.03.064     Document Type: Article

References (57)

1. Campbell R.D., Law S.K., Reid K.B., and Sim R.B. Structure, organization, and regulation of the complement genes. Annu. Rev. Immunol. 6 (1988) 161-195
2. Ember J.A.a.J., and Mark A. Characterization of complement anaphylatoxins and their biological responses. In: Volanakis J.E., et al. (Ed). The Human Complement System in Health and Disease (1998), Marcel Dekker, New York 241
3. Kohl J. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Mol. Immunol. 38 (2001) 175-187
4. Sahu A., and Lambris J.D. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology 49 (2000) 133-148
5. Szakonyi G., Guthridge J.M., Li D., Young K., Holers V.M., and Chen X.S. Structure of complement receptor 2 in complex with its C3d ligand. Science 292 (2001) 1725-1728
6. Morikis D., and Lambris J.D. The electrostatic nature of C3d-complement receptor 2 association. J. Immunol. 172 (2004) 7537-7547
7. Favoreel H.W., Van de Walle G.R., Nauwynck H.J., and Pensaert M.B. Virus complement evasion strategies. J. Gen. Virol. 84 (2003) 1-15
8. Cordes F.S., Roversi P., Kraiczy P., Simon M.M., Brade V., Jahraus O., et al. A novel fold for the factor H-binding protein BbCRASP-1 of Borrelia burgdorferi. Naure Struct. Mol. Biol. 12 (2005) 276-277
9. Alitalo A., Meri T., Ramo L., Jokiranta T.S., Heikkila T., Seppala I.J., et al. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect. Immun. 69 (2001) 3685-3691
10. Pandiripally V., Gregory E., and Cue D. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect. Immun. 70 (2002) 6206-6214
11. Valenzuela J.G., Charlab R., Mather T.N., and Ribeiro J.M. Purification, cloning, and expression of a novel salivary anticomplement protein from the tick Ixodes scapularis. J. Biol. Chem. 275 (2000) 18717-18723
12. Ribeiro J.M., and Spielman A. Ixodes dammini: salivary anaphylatoxin inactivating activity. Expt. Parasitol. 62 (1986) 292-297
13. Nunn M.A., Sharma A., Paesen G.C., Adamson S., Lissina O., Willis A.C., and Nuttall P.A. Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata. J. Immunol. 174 (2005) 2084-2091
14. Paesen G.C., Adams P.L., Harlos K., Nuttall P.A., and Stuart D.I. Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol. Cell 3 (1999) 661-671
15. Mans B.J., Louw A.I., and Neitz A.W. The major tick salivary gland proteins and toxins from the soft tick, Ornithodoros savignyi, are part of the tick Lipocalin family: implications for the origins of tick toxicoses. Mol. Biol. Evol. 20 (2003) 1158-1167
16. Langley R., Wines B., Willoughby N., Basu I., Proft T., and Fraser J.D. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J. Immunol. 174 (2005) 2926-2933
17. van den Elsen J.M., Martin A., Wong V., Clemenza L., Rose D.R., and Isenman D.E. X-ray crystal structure of the C4d fragment of human complement component C4. J. Mol. Biol. 322 (2002) 1103-1115
18. Nagar B., Jones R.G., Diefenbach R.J., Isenman D.E., and Rini J.M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280 (1998) 1277-1281
19. Huber R., Scholze H., Paques E.P., and Deisenhofer J. Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z. Physiol. Chem. 361 (1980) 1389-1399
20. Janssen B.J., Huizinga E.G., Raaijmakers H.C., Roos A., Daha M.R., Nilsson-Ekdahl K., et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437 (2005) 505-511
21. Janssen B.J., Christodoulidou A., McCarthy A., Lambris J.D., and Gros P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444 (2006) 213-216
22. Wiesmann C., Katschke K.J., Yin J., Helmy K.Y., Steffek M., Fairbrother W.J., et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444 (2006) 217-220
23. Abdul Ajees A., Gunasekaran K., Volanakis J.E., Narayana S.V., Kotwal G.J., and Murthy H.M. The structure of complement C3b provides insights into complement activation and regulation. Nature 444 (2006) 221-225
24. Zuiderweg E.R., Nettesheim D.G., Mollison K.W., and Carter G.W. Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. Biochemistry 28 (1989) 172-185
25. Zhang X., Boyar W., Toth M.J., Wennogle L., and Gonnella N.C. Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy. Proteins: Struct. Funct. Genet. 28 (1997) 261-267
26. Bramham J., Thai C.T., Soares D.C., Uhrin D., Ogata R.T., and Barlow P.N. Functional insights from the structure of the multifunctional C345C domain of C5 of complement. J. Biol. Chem. 280 (2005) 10636-10645
27. Thai C.T., and Ogata R.T. Expression and characterization of the C345C/NTR domains of complement components C3 and C5. J. Immunol. 171 (2003) 6565-6573
28. Thai C.T., and Ogata R.T. Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5. J. Immunol. 173 (2004) 4547-4552
29. Sandoval A., Ai R., Ostresh J.M., and Ogata R.T. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5. J. Immunol. 165 (2000) 1066-1073
30. Thomas T.C., Rollins S.A., Rother R.P., Giannoni M.A., Hartman S.L., Elliott E.A., et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol. Immunol. 33 (1996) 1389-1401
31. Hill A. Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Clin. Advan. Hematol. Oncol. 3 (2005) 849-850
32. Armstrong P.W., Mahaffey K.W., Chang W.C., Weaver W.D., Hochman J.S., Theroux P., et al. Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction. Am. Heart J. 151 (2006) 787-790
33. Sellke F.W., and Boodhwani M. Inhibition of complement activation in cardiac surgery. J. Thorac. Cardiovasc. Surg. 131 (2006) 266-267
34. Rother R.P., Mojcik C.F., and McCroskery E.W. Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus. Lupus 13 (2004) 328-334
35. Hepburn N.J., Williams A.S., Nunn M.A., Chamberlain-Banoub J.C., Hamer J., Morgan B.P., and Harris C.L. In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubata. J. Biol. Chem. 282 (2007) 8292-8299
36. Paesen G.C., Adams P.L., Nuttall P.A., and Stuart D.L. Tick histamine-binding proteins: lipocalins with a second binding cavity. Biochim. Biophys. Acta 1482 (2000) 92-101
37. Lee B., and Richards F.M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55 (1971) 379-400
38. Holm L., and Sander C. Dali: a network tool for protein structure comparison. Trends Biochem. Sci. 20 (1995) 478-480
39. Mans B.J., Venter J.D., Vrey P.J., Louw A.I., and Neitz A.W. Identification of putative proteins involved in granule biogenesis of tick salivary glands. Electrophoresis 22 (2001) 1739-1746
40. Waxman L., and Connolly T.M. Isolation of an inhibitor selective for collagen-stimulated platelet aggregation from the soft tick Ornithodoros moubata. J. Biol. Chem. 268 (1993) 5445-5549
41. Hilger C., Bessot J.C., Hutt N., Grigioni F., De Blay F., Pauli G., and Hentges F. IgE-mediated anaphylaxis caused by bites of the pigeon tick Argas reflexus: cloning and expression of the major allergen Arg r 1. J. Allergy Clin. Immunol. 115 (2005) 617-622
42. Baker N.A., Sept D., Joseph S., Holst M.J., and McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98 (2001) 10037-10041
43. Parker C.L., and Sodetz J.M. Role of the human C8 subunits in complement-mediated bacterial killing: evidence that C8 gamma is not essential. Mol. Immuno. 39 (2002) 453-458
44. Ortlund E., Parker C.L., Schreck S.F., Ginell S., Minor W., Sodetz J.M., and Lebioda L. Crystal structure of human complement protein C8gamma at 1.2 Å resolution reveals a lipocalin fold and a distinct ligand binding site. Biochemistry 41 (2002) 7030-7037
45. Krissinel E.A.H.K. Detection of protein assemblies in crystals. In: Berthold M.R. (Ed). Lecture Notes in Computer Science vol. 3695 (2005), Springer, Berlin 163-174
46. Cheng Y., Austin S.C., Rocca B., Koller B.H., Coffman T.M., Grosser T., et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296 (2002) 539-541
47. Leslie A.G. The integration of macromolecular diffraction data. Acta Crystallog. sect. D 62 (2006) 48-57
48. Evans P. Scaling and assessment of data quality. Acta Crystallog. sect. D 62 (2006) 72-82
49. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog 50 (1994) 157-163
50. Claude J.B., Suhre K., Notredame C., Claverie J.M., and Abergel C. CaspR: a web server for automated molecular replacement using homology modelling. Nucl. Acids Res. 32 (2004) W606-W609
51. McRee D.E. XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125 (1999) 156-165
52. Blanc E., Roversi P., Vonrhein C., Flensburg C., Lea S.M., and Bricogne G. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallog. sect. D 60 (2004) 2210-2221
53. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
54. Kleywegt G.J., and Jones T.A. A super position. CCP4/ESF-EACBM Newsletter on Protein Crystallography 31 (1994) 9-14
55. Risler J.L., Delorme M.O., Delacroix H., and Henaut A. Amino acid substitutions in structurally related proteins. A pattern recognition approach. Determination of a new and efficient scoring matrix. J. Mol. Biol. 204 (1988) 1019-1029
56. Gouet P., Robert X., and Courcelle E. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucl. Acids Res. 31 (2003) 3320-3323
57. Wallace A.C., Laskowski R.A., and Thornton J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8 (1995) 127-134